United States v. Armstrong

550 F.3d 382, 2008 U.S. App. LEXIS 25289, 2008 WL 4958144
CourtCourt of Appeals for the Fifth Circuit
DecidedNovember 21, 2008
Docket07-30286
StatusPublished
Cited by83 cases

This text of 550 F.3d 382 (United States v. Armstrong) is published on Counsel Stack Legal Research, covering Court of Appeals for the Fifth Circuit primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
United States v. Armstrong, 550 F.3d 382, 2008 U.S. App. LEXIS 25289, 2008 WL 4958144 (5th Cir. 2008).

Opinion

CARL E. STEWART, Circuit Judge:

Defendants Cherlyn Armstrong Scherer Prejean (“Armstrong”), the Scherer Corporate Defendants, 1 and Dr. Suzette Cul-lins (“Dr. Cullins” and collectively, the “Defendants”) were convicted following a jury trial of offenses relating to a scheme to illegally dispense certain controlled substances in violation of the Controlled Substances Act (the “CSA”), 21 U.S.C. §§ 846, 841(a). Armstrong and Dr. Cullins appeal from their convictions under the CSA. Armstrong also challenges certain eviden-tiary rulings that she argues tainted her conviction for conspiracy to commit money laundering. Dr. Cullins appeals the reasonableness of her sentence. For the following reasons, we AFFIRM in part, REVERSE in part, and REMAND to the district court.

FACTUAL AND PROCEDURAL BACKGROUND

Armstrong, a Registered Nurse, was the owner and operator of weight loss and pain management clinics and pharmacies, located in Slidell, Metairie, and, at various times, Harvey or Gretna, Louisiana. Her family members provided continual and active assistance in their operation. From approximately January 1998 to August 2000, the clinics’ focus was on weight loss, and prescriptions were given for controlled-substance weight-loss drugs. In or around August 2000, the focus changed to pain management, and prescriptions were given for controlled-substance pain management drugs. The three drugs (“trinity drugs”) most often prescribed at the clinics and dispensed at the pharmacies during this time included: (1) Hydrocodone; 2 (2) Alprazolam or Diazepam; 3 (3) and Cariso-prodol. 4 Armstrong’s pharmacies only stocked and sold the generic versions of the trinity drugs. The drugs have a high abuse potential and a high illegal street market value.

After an investigation, agents of the Drug Enforcement Agency (“DEA”) shut the clinics down in April 2005. Armstrong, the various corporate entities which she established, including the pharmacies and clinics (“Corporate Defendants”), and three physicians employed at the clinics 5 were charged with knowingly and intentionally conspiring to dispense Schedule III and IV controlled substances in violation of the CSA. See 21 U.S.C. § 846. A superseding indictment was la *387 ter returned charging an additional twenty-six specific instances (counts 2-27) in which Armstrong, the clinics, and the pharmacies, aided and abetted by persons known and unknown — including Drs. Cul-lins, Guenther, and DeLoach — knowingly and intentionally dispensed controlled substances, outside the scope of professional practice and not for a legitimate medical purpose, in violation of 21 U.S.C. § 841(a) 6 and 18 U.S.C. § 2. These alleged instances involved either an undercover DEA agent as a patient or an actual patient as an informant at the direction of the DEA. Lastly, Armstrong and the Corporate Defendants were charged with conspiring to launder money involving the proceeds of the illegal drug activity, in violation of 18 U.S.C. § 1956(h) (count 28).

Prior to trial, two of the co-defendant physicians named in the superseding indictment, Dr. Guenther and Dr. DeLoach, pled guilty to various charges. Dr. Guen-ther pled guilty to all charged counts, 7 and Dr. DeLoach pled guilty to misprision of a felony in violation of 18 U.S.C. § 4. The remaining Defendants — Armstrong, Dr. Cullins, and the Corporate Defendants— proceeded to trial. The jury found all Defendants guilty of the conspiracy charged in count one and various substantive counts charged in counts two through 27 of the superseding indictment. 8 Armstrong and the Corporate Defendants were also found guilty on count 28, conspiring to commit money laundering.

Following trial, Armstrong and Dr. Cul-lins filed a motion for judgment of acquittal or in the alternative for a new trial, which was denied. The Government filed sentencing memoranda seeking an upward departure based on injuries to specific victims, including patients, their families, and the community, because these victims were not taken into account by the Sentencing Guidelines. Armstrong and Dr. Cullins responded. At the sentencing hearing, the district court adopted the fac *388 tual findings and recommendations of the pre-sentencing report (“PSR”). Dr. Cul-lins did not object to the factual findings of her PSR. The district court sentenced Dr. Cullins to sixty-month sentences for each of her CSA convictions, to be served concurrently. Thereafter, the district court also sentenced Armstrong to sixty-month concurrent sentences for each of her CSA convictions, and a seventy-month concurrent sentence for conspiracy to commit money laundering. Armstrong, Dr. Cul-lins, and Corporate Defendants timely appealed. This Court dismissed Corporate Defendants’ appeal for want of prosecution on August 24, 2007. 9 As a result, this Court reviewed only the appeals of Armstrong and Dr. Cullins (together, the “Appellants”).

ILLEGAL DISPENSATION OF CONTROLLED SUBSTANCES

I. Sufficiency of the Evidence

A. Lack of Expert Testimony

Armstrong and Dr. Cullins argue that because the Government failed to present expert testimony regarding what the professional standard of care should be for a physician prescribing controlled substances to chronic pain patients, there was insufficient evidence for the jury to find beyond a reasonable doubt that Appellants’ conduct was outside the course of professional conduct.

1. Standard of Review

In evaluating whether the evidence produced at trial is sufficient to support a jury conviction, this Court examines whether a rational jury, viewing the evidence in the light most favorable to the prosecution, could have found the essential elements of the offense to be satisfied beyond a reasonable doubt. See United States v. Miles, 360 F.3d 472, 476-77 (5th Cir.2004). In reviewing the evidence, all reasonable inferences are drawn in favor of the jury’s verdict. Id. This Court does not evaluate whether the jury’s verdict was correct, but rather, whether the jury’s decision was rational. Id.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

United States v. Lamartiniere
100 F.4th 625 (Fifth Circuit, 2024)
United States v. Wilson
Fifth Circuit, 2024
United States v. Little
Fifth Circuit, 2023
United States v. Shah
84 F.4th 190 (Fifth Circuit, 2023)
United States v. Cortez-Balderas
74 F.4th 786 (Fifth Circuit, 2023)
United States v. Capistrano
74 F.4th 756 (Fifth Circuit, 2023)
United States v. Ferris
52 F.4th 235 (Fifth Circuit, 2022)
United States v. Khan
989 F.3d 806 (Tenth Circuit, 2021)
United States v. Xiulu Ruan
966 F.3d 1101 (Eleventh Circuit, 2020)
United States v. Marie Neba
901 F.3d 260 (Fifth Circuit, 2018)
United States v. Sherrie Bennett
874 F.3d 236 (Fifth Circuit, 2017)
United States v. Elechi Oti
872 F.3d 678 (Fifth Circuit, 2017)
United States v. Alexander Jimenez, III
692 F. App'x 192 (Fifth Circuit, 2017)
United States v. Bennett
230 F. Supp. 3d 546 (S.D. Mississippi, 2017)
United States v. Oliver Calderon
665 F. App'x 356 (Fifth Circuit, 2016)
United States v. Ernest Singleton
626 F. App'x 589 (Sixth Circuit, 2015)
United States v. Francisco Colorado Cessa
785 F.3d 165 (Fifth Circuit, 2015)

Cite This Page — Counsel Stack

Bluebook (online)
550 F.3d 382, 2008 U.S. App. LEXIS 25289, 2008 WL 4958144, Counsel Stack Legal Research, https://law.counselstack.com/opinion/united-states-v-armstrong-ca5-2008.